Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Leborgne

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Blood Advances|January 4, 2018
Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectorsAmine Meliani, Florence Boisgerault, Zachary Fitzpatrick, et al.
Nature Communications|October 7, 2018
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administrationAmine Meliani, Florence Boisgerault, Romain Hardet, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2017
Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral SeroreactivityNicole K Paulk, Katja Pekrun, Erhua Zhu, et al.
Nature Medicine|June 3, 2020
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodiesChristian Leborgne, Elena Barbon, Jeffrey M Alexander, et al.
Science Translational Medicine|December 1, 2017
Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidaseFrancesco Puzzo, Pasqualina Colella, Maria G Biferi, et al.
Science Advances|September 21, 2022
Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disordersJihad El Andari, Edith Renaud-Gabardos, Warut Tulalamba, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patientsCaroline Le Guiner, Marie Montus, Laurent Servais, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Blood Advances|January 4, 2018
Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectorsAmine Meliani, Florence Boisgerault, Zachary Fitzpatrick, et al.
Nature Communications|October 7, 2018
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administrationAmine Meliani, Florence Boisgerault, Romain Hardet, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2017
Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral SeroreactivityNicole K Paulk, Katja Pekrun, Erhua Zhu, et al.
Nature Medicine|June 3, 2020
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodiesChristian Leborgne, Elena Barbon, Jeffrey M Alexander, et al.
Science Translational Medicine|December 1, 2017
Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidaseFrancesco Puzzo, Pasqualina Colella, Maria G Biferi, et al.
Science Advances|September 21, 2022
Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disordersJihad El Andari, Edith Renaud-Gabardos, Warut Tulalamba, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patientsCaroline Le Guiner, Marie Montus, Laurent Servais, et al.
Pageof 5